COOPERS BOVILIS ROTAVEC CORONA CALF SCOURS VACCINE

국가: 오스트레일리아

언어: 영어

출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)

유효 성분:

BOVINE ROTAVIRUS (NCDV); CLOSTRIDIUM PERFRINGENS TYPE C TOXOID; ESCHERICHIA COLI K99 PILUS ANTIGENS; CLOSTRIDIUM PERFRINGENS TYPE D TOXOID; BOVINE CORONAVIRUS (INACTIVATED)

제공처:

INTERVET AUSTRALIA PTY LIMITED

INN (국제 이름):

E.coli+vaccine - bovine coronavirus+vaccine - bovine rotavirus + others

약제 형태:

MISC. VACCINES OR ANTI SERA

구성:

BOVINE ROTAVIRUS (NCDV) BIOLOGICAL-VIRUS Active 1.0 RP; CLOSTRIDIUM PERFRINGENS TYPE C TOXOID VACCINE-TOXOID Active 10.0 IU/ml; ESCHERICHIA COLI K99 PILUS ANTIGENS VACCINE-MICROBIAL Active 1.0 RP; CLOSTRIDIUM PERFRINGENS TYPE D TOXOID VACCINE-TOXOID Active 2.0 IU/ml; BOVINE CORONAVIRUS (INACTIVATED) VACCINE-VIRAL Active 1.0 RP

패키지 단위:

100mL x 50 doses; 20mL x 10 doses

수업:

VM - Veterinary Medicine

Manufactured by:

INTERVET AUSTRALIA

치료 그룹:

COW | HEALTHY PREGNANT HEIFER | BOVINE | FEMALE CATTLE

치료 영역:

IMMUNOTHERAPY

치료 징후:

BOVINE ROTAVIRUSES | NEONATAL CALF DIARRHEA | NEONATAL ENTEROTOXEMIA | RAISE COLOSTRAL ANTIBODIES | AGAINST BOVINE ROTAVIRUS AND | CORONAVIRUS | ENTEROTOXIGENIC E.COLI PILUS | G6 AND G10 | TYPE K99

제품 요약:

Poison schedule: 0; Withholding period: WITHHOLDING PERIOD NIL. TRADE ADVICE: Export Slaughter Interval (ESI): ESI not required.; Host/pest details: COW: [BOVINE ROTAVIRUSES, NEONATAL CALF DIARRHEA, NEONATAL ENTEROTOXEMIA, RAISE COLOSTRAL ANTIBODIES]; HEALTHY PREGNANT HEIFER: [BOVINE ROTAVIRUSES, NEONATAL CALF DIARRHEA, NEONATAL ENTEROTOXEMIA, RAISE COLOSTRAL ANTIBODIES]; Poison schedule: 0; Withholding period: WITHHOLDING PERIOD NIL. TRADE ADVICE: Export Slaughter Interval (ESI): ESI n ot required.; Host/pest details: COW: [BOVINE ROTAVIRUSES, NEONATAL CALF DIARRHEA, NEONATAL ENTEROTOXEMIA, RAISE COLOSTRAL ANTIBODIES]; HEALTHY PREGNANT HEIFER: [BOVINE ROTAVIRUSES, NEONATAL CALF DIARRHEA, NEONATAL ENTEROTOXEMIA, RAISE COLOSTRAL ANTIBODIES]; Poison schedule: 0; Withholding period: ; Host/pest details: COW: [BOVINE ROTAVIRUSES, NEONATAL CALF DIARRHEA, NEONATAL ENTEROTOXEMIA, RAISE COLOSTRAL ANTIBODIES]; HEALTHY PREGNANT HEIFER: [BOVINE ROTAVIRUSES, NEONATAL CALF DIARRHEA, NEONATAL ENTEROTOXEMIA, RAISE COLOSTRAL ANTIBODIES]; For use in healthy pregnant heifers & cows as an aid in the prevention of neonatal calf diarrhoea caused by enterotoxigenic E. coli pilus type K99, bovine rotavirus G6 & G10, neonatal enterotoxaemia caused by C. perfringens Types C & D, and as an aid . .See Precautions on leaflet

승인 상태:

Registered

승인 날짜:

2023-07-01

환자 정보 전단

+
RLP
TEMPLATE
FOR
RELEVANT
LABEL
PRODUCTS)
ApEroved
PARTICU
ARS
(RLPS)
(VETERINARY
Select appropriate:
[]
New Product (include
all
applicable RLPs) OR
1&1
Variation
(highlight
instructions
that
are
being
varied).
Approval
no.
of label
being
varied:
[APVMA NO. 61447/ATS NO. 49981]
Signal heading:
FOR
ANIMAL
TREATMENT
ONLY
PRODUCT
NAME:
COOPERS®
BOVILIS®
ROT
AVEC
CORONA
CALF
SCOURS
VACCINE
ACTIVE
CONSTITUENTLS:
ACTIVE
CONSTITUENTS:
POTENCY UNITS:
A multiple antigen
product
which includes
cell-free
extract
of
K99
pilus type
of
_Escherichia _
_coli _
;::
I
RP
unit
Bovine Coronavirus {inactivated), Type I (mebus-like) and Type 3
;::1
RP
unit
Bovine Rotavirus (inactivated), Type G6 and Type G I
0
;::1
RP
unit
_Clostridium _
_perfringens _
Type C toxoid
10.0
iu/ml
_Clostridium _
_perfringens _
Type D toxoid
2.0
iu/ml
CONTAINS:
0.1
gil
thiomersal
Statement
of
Recommended
for
use
in
healthy pregnant heifers and cows as an
aid
in
the
CLAIMS;
prevention
of
neonatal calf diarrhoea
by
enterotoxigenic
E.
coli
pilus type K99, bovine
rotaviruses G6 and G I
0,
neonatal
enterotoxemia
caused
by
C.
_perfringens _
Types C and
D,
and as
an
aid
in
the
control
of
neonatal calf diarrhoea caused by bovine
CORONAVIRUSES.
.
For
the
active immunisation
of
pregnant cows and heifers
to
raise colostral antibodies
against bovine rotavirus and coronavirus, enterotoxigenic
_E. _
_coli _
pilus
type
K99 and
neonatal
enterotoxemia
caused by
C.
_perfringens _
Types C and
D.
Calves fed colostrum from vaccinated cows during
the
first four days
of
life,
will
receive antibodies
that
have been
demonstrated
to
aid
the
prevention
of
neonatal calf
diarrhoea caused
by
enterotoxigenic
_E. _
coli
pilus type K99, bovine rotaviruses,
enterotoxemia
caused by
C.
_perfringens _
Types C and
D,
and
to
aid
in
the
control
of
neonatal calf diarrhoea caused by bovine coronaviruses.
In
addition calves
exposed
to
BOVINE ROTAVIRUS
AND
CORONAVIRUS DISEASE
WERE
SHOWN
TO
SHED LESS VIRUS THAN
unvaccinated controls
thereby
reducing environmental exposure.
In
the
face
of
heavy c